The global genetic analysis market size accounted for US$ 10.55 billion in 2023 and is projected to reach around USD 23.60 billion by 2033, growing at a CAGR of 8.39% from 2024 to 2033.
Key Points
- North America dominated the market in 2023.
- By product, the reagents & kits segment dominated the market in 2023.
- By test, the disease diagnostic testing segment dominated the largest share in 2023.
- By technology, the real-time PCR system segment dominated the genetic analysis market in 2023.
- By application, the infectious diseases segment dominated the market in 2023.
- By end-use, the research & development laboratories segment dominated the market in 2023.
Report Summary
The global genetic analysis market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the genetic analysis market across the globe.
A comprehensive estimate on the genetic analysis market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of genetic analysis during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3922
Genetic Analysis Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 8.39% |
| Global Market Size in 2023 | USD 10.55 Billion |
| Global Market Size by 2033 | USD 23.60 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Test, By Technology, By Application, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized genetic analysis market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Behavioral and Mental Health Software Market Size Report by 2033
Market Players
The report includes the profiles of key genetic analysis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In December 2023, SNP Therapeutics Inc. will introduce a range of prenatal nutrition items in addition to its GenateTM Test, a prenatal genetic screening tool. With the help of Generate Prenatal Nutrition, women can tailor their diet to their unique gene variations related to food metabolism.
- In July 2023, US-based Quest Diagnostics, a supplier of diagnostic information services, introduced Genetic Insights, its first consumer-focused genetic test. Due to the new service, People will better understand their risk of inheriting illness disorders. Personalized health reports and access to genetic counseling, a feature not often provided with comparable services, will be included in the program.
Genetic Analysis Market Companies
- Thermo Fisher Scientific
- Abbott Laboratories
- PerkinElmer, Inc.
- BioRad Laboratories
- AutoGenomics Inc.
- ELITech Group
- IntegraGen
- Quest Diagnostics Inc.
- Hoffmann-La Roche AG
- Celera Group
- Qiagen
- Danaher (Cepheid)
Segments Covered in the Report
By Product
- Reagents & Kits
- Instruments
- Software
By Test
- Predictive Genetic Testing
- Carrier Testing
- Prenatal and Newborn Testing
- Disease Diagnostic Testing
- Pharmacogenomic Testing
- Others
By Technology
- Next-Generation Sequencing (NGS)
- Real-Time PCR System
- Others
By Application
- Cancer
- Genetic Diseases
- Cardiovascular Diseases
- Rare Diseases
- Infectious Diseases
- Others
By End-use
- Hospitals
- Research & Development Laboratories
- Diagnostic Centers
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Genetic Analysis Market
5.1. COVID-19 Landscape: Genetic Analysis Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Genetic Analysis Market, By Product
8.1. Genetic Analysis Market, by Product, 2024-2033
8.1.1. Reagents & Kits
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Software
8.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Genetic Analysis Market, By Test
9.1. Genetic Analysis Market, by Test, 2024-2033
9.1.1. Predictive Genetic Testing
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Carrier Testing
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Prenatal and Newborn Testing
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Disease Diagnostic Testing
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Pharmacogenomic Testing
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Genetic Analysis Market, By Technology
10.1. Genetic Analysis Market, by Technology, 2024-2033
10.1.1. Next-Generation Sequencing (NGS)
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Real-Time PCR System
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Genetic Analysis Market, By Application
11.1. Genetic Analysis Market, by Application, 2024-2033
11.1.1. Cancer
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Genetic Diseases
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Cardiovascular Diseases
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Rare Diseases
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Infectious Diseases
11.1.5.1. Market Revenue and Forecast (2021-2033)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Genetic Analysis Market, By End-use
12.1. Genetic Analysis Market, by End-use, 2024-2033
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Research & Development Laboratories
12.1.2.1. Market Revenue and Forecast (2021-2033)
12.1.3. Diagnostic Centers
12.1.3.1. Market Revenue and Forecast (2021-2033)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 13. Global Genetic Analysis Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.5. Market Revenue and Forecast, by End-use (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.6.5. Market Revenue and Forecast, by End-use (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Forecast, by Test (2021-2033)
13.1.7.3. Market Revenue and Forecast, by Technology (2021-2033)
13.1.7.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.7.5. Market Revenue and Forecast, by End-use (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.5. Market Revenue and Forecast, by End-use (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.7. Market Revenue and Forecast, by Application (2021-2033)
13.2.8. Market Revenue and Forecast, by End-use (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.9.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.10. Market Revenue and Forecast, by Application (2021-2033)
13.2.11. Market Revenue and Forecast, by End-use (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.12.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.12.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.13. Market Revenue and Forecast, by End-use (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Forecast, by Test (2021-2033)
13.2.14.3. Market Revenue and Forecast, by Technology (2021-2033)
13.2.14.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.15. Market Revenue and Forecast, by End-use (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.5. Market Revenue and Forecast, by End-use (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.7. Market Revenue and Forecast, by End-use (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.9. Market Revenue and Forecast, by End-use (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.10.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.10.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.10.5. Market Revenue and Forecast, by End-use (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Forecast, by Test (2021-2033)
13.3.11.3. Market Revenue and Forecast, by Technology (2021-2033)
13.3.11.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.11.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.7. Market Revenue and Forecast, by End-use (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.9. Market Revenue and Forecast, by End-use (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.10.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.10.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.10.5. Market Revenue and Forecast, by End-use (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Forecast, by Test (2021-2033)
13.4.11.3. Market Revenue and Forecast, by Technology (2021-2033)
13.4.11.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.11.5. Market Revenue and Forecast, by End-use (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.5. Market Revenue and Forecast, by End-use (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.6.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.7. Market Revenue and Forecast, by End-use (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Forecast, by Test (2021-2033)
13.5.8.3. Market Revenue and Forecast, by Technology (2021-2033)
13.5.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.8.5. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 14. Company Profiles
14.1. Thermo Fisher Scientific
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott Laboratories
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. PerkinElmer, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. BioRad Laboratories
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. AutoGenomics Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. ELITech Group
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. IntegraGen
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Quest Diagnostics Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Hoffmann-La Roche AG
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Celera Group
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
